Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/12/2026

Evidence‑Based Recommendations for Acute Seizure Evaluation and Management in Adults

1. Immediate Acute Management of Ongoing Seizures

  • Benzodiazepines are recommended as first‑line therapy for any seizure lasting ≥ 5 minutes, because seizures of this duration are unlikely to self‑terminate and meet criteria for status epilepticus. (Strong recommendation) 1
  • If seizures persist after adequate benzodiazepine dosing (refractory status epilepticus), intravenous fosphenytoin, levetiracetam, or valproate may be used as second‑line agents; each demonstrates comparable efficacy (≈ 45‑47 % seizure cessation within 60 minutes). (Moderate recommendation) 1
  • Patients with status epilepticus or refractory seizures should be admitted for continuous monitoring and advanced care. (Class I recommendation) 1

2. Classification of Seizures

  • Provoked (acute symptomatic) seizures are defined as seizures occurring within 7 days of an acute precipitating insult (e.g., electrolyte disturbance, medication effect, metabolic derangement, or acute CNS injury). 2
  • Unprovoked seizures include remote symptomatic seizures that occur > 7 days after a prior CNS injury such as stroke or traumatic brain injury. (Both acute and remote definitions) [2][3]

3. Decision to Initiate Antiepileptic Drugs (AEDs)

  • Do not start AED therapy when a provoked seizure has an identifiable and correctable cause; treatment should focus on correcting the underlying factor. [2][3]
  • For a first unprovoked seizure in a patient without known brain disease or injury, initiating AEDs provides minimal benefit (number needed to treat = 14 to prevent one recurrence over 2 years) and does not alter long‑term recurrence risk. (Weak recommendation) 3
  • When a first unprovoked seizure occurs in the context of a remote brain disorder (e.g., prior stroke, traumatic brain injury, cerebral palsy), AED initiation may be considered after shared decision‑making with neurology. [2][3]
  • AED therapy should be started for patients who have experienced two or more unprovoked seizures, as the risk of further seizures rises markedly (from 33‑50 % to ≈ 75 % within 5 years). (Strong recommendation) 3

4. Hospital Admission Criteria

  • Patients with a first unprovoked seizure who have returned to their baseline clinical status in the emergency department do not require admission. (Class II recommendation) 3
  • Admission is indicated for:
    • Provoked seizures with an uncorrected underlying cause.
    • Recurrent seizures or incomplete recovery to baseline.
    • Status epilepticus or refractory seizures. (All supported by evidence) 1

5. Prognostic and Epidemiologic Data

  • In patients with a first unprovoked seizure and no structural brain abnormality, the number needed to treat with AEDs to prevent one recurrence within 2 years is 14; early treatment only delays, but does not prevent, recurrence at 5 years. (Evidence level moderate) 3
  • The risk of seizure recurrence after a second unprovoked seizure increases to approximately 75 % within 5 years, compared with 33‑50 % after a single event. (Evidence level moderate) 3

All statements are derived from peer‑reviewed evidence published in Annals of Emergency Medicine (2014) and reflect current emergency medicine and neurology guideline consensus.

Management of Seizure-Like Episodes

Initial Assessment and Stabilization

  • The American College of Emergency Physicians recommends distinguishing true seizures from seizure mimics, stabilizing the patient, identifying provoked versus unprovoked etiology, and determining whether antiepileptic therapy and hospital admission are indicated based on seizure classification and recurrence risk 4, 5
  • Many conditions mimic seizures, including syncope with brief stiffening/jerks, concussion, rigors, and psychogenic nonepileptic seizures, and a thorough history is essential to distinguish these from true generalized convulsive seizures 4, 5
  • True generalized convulsive seizures involve generalized movements with unresponsiveness reflecting excessive synchronous cortical electrical activity 5, 6

Classification: Provoked vs. Unprovoked Seizures

  • The American Academy of Neurology defines provoked seizures as those occurring at the time of or within 7 days of an acute neurologic, systemic, metabolic, or toxic insult, such as hyponatremia, withdrawal, toxic ingestions, encephalitis, CNS mass lesions, or intracranial hemorrhage 4, 6, 7
  • Unprovoked seizures are those without acute precipitating factors, including remote symptomatic seizures from CNS/systemic insult >7 days past, such as prior stroke, traumatic brain injury, or cerebral palsy 4, 5, 6

Decision to Initiate Antiepileptic Therapy

  • The World Health Organization explicitly recommends against routine prescription of antiepileptic drugs after a first unprovoked seizure, as early treatment only prolongs the time to the next event without changing 5-year outcomes 8, 9
  • The number needed to treat to prevent one seizure recurrence in the first 2 years is 14 patients, and the strategy of waiting until a second seizure before initiating medication is considered appropriate 9, 8
  • For patients with a first unprovoked seizure and remote history of brain disease or injury, such as stroke, traumatic brain injury, or cerebral palsy, antiepileptic medication may be initiated 7, 10
  • Patients with 2-3 recurrent unprovoked seizures have substantially increased recurrence risk and should receive antiepileptic therapy, with levetiracetam recommended as first-line monotherapy 9, 7

Decision for Hospital Admission

  • Patients with a first unprovoked seizure who have returned to clinical baseline in the ED do not require hospital admission, but those with underlying brain disorders should be admitted for observation for at least 6 hours, preferably 24 hours 9, 10
  • More than 85% of early seizure recurrences occur within 6 hours, and observation during this highest-risk period is critical 9, 8
  • Admission decisions for provoked seizures depend on the underlying acute cause and whether it has been corrected, and patients with recurrent seizures or incomplete recovery should be admitted 9, 7

Disposition and Follow-Up

  • Urgent neurology follow-up within 1-2 weeks is recommended for all patients with a first seizure, and brain MRI and EEG should be obtained in the outpatient setting to characterize structural abnormalities and assess for epileptiform activity 10

Management of Focal Seizures with Rhythmic Jaw Jerking – Evidence‑Based Summary

Acute Pharmacologic Management

  • Second‑line intravenous antiepileptic agents (used after an adequate benzodiazepine dose) have the following efficacy and safety profiles:
    • Valproate 20–30 mg/kg (max ≈ 3 g) – ≈ 88 % seizure termination, 0 % hypotension risk; preferred unless the patient is of child‑bearing potential because of teratogenicity. 11
    • Levetiracetam 30 mg/kg (max ≈ 3 g) – ≈ 70 % seizure termination, ≈ 0.7 % hypotension risk; minimal cardiovascular effects and no requirement for cardiac monitoring. 11
    • Fosphenytoin 20 mg PE/kg (max ≈ 150 PE/min) – ≈ 84 % seizure termination, but ≈ 12 % hypotension risk, necessitating continuous ECG and blood‑pressure monitoring. 11

Diagnostic Evaluation

  • Provoked vs. unprovoked seizures:

    • Provoked seizures occur within 7 days of an acute insult such as electrolyte disturbance, hypoglycemia, drug toxicity/withdrawal, acute CNS infection, stroke, or traumatic brain injury. 11
    • Unprovoked seizures lack an acute precipitant or occur >7 days after a remote CNS injury (e.g., prior stroke or traumatic brain injury). 11
  • Laboratory work‑up beyond glucose and sodium (ordered according to clinical context): comprehensive metabolic panel, antiepileptic drug levels (if known epilepsy), pregnancy test (if child‑bearing potential), and toxicology screen for suspected substance exposure. 12

  • Neuroimaging yield: emergent non‑contrast head CT identifies abnormalities in 23–41 % of first‑time seizure presentations and in ≈ 34 % of all seizure patients. 12

Decision to Initiate Antiepileptic Drugs (AEDs)

  • Provoked seizures – do not start AED therapy in the emergency department; focus on correcting the underlying acute cause. 11

  • First unprovoked seizure – routine AED initiation is not recommended; the number needed to treat is 14 to prevent one recurrence over two years, and early treatment only delays—not prevents—recurrence at five years. 11

  • Patients with remote brain disease or injury (e.g., prior stroke, traumatic brain injury, cerebral malformation, tumor) – consider AED initiation in collaboration with neurology, given the higher risk of recurrence. 11

Disposition

  • Patients who have returned to their clinical baseline in the emergency department do not require hospital admission. 11

All statements are supported by the cited evidence.

REFERENCES

7

Etiology and Management of Recurrent Generalized Seizures [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

8

Risk of Seizure Recurrence After First Unprovoked Generalized Seizure [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

10

Approach to First-Time Seizure in Patients with Cerebral Palsy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025